Nurix Therapeutics Inc (NRIX)
Healthcare
Biotechnology
23.20 $
+0.0%
vs. previous close
Closing price · As of: 3. Aug 2026
Nurix Therapeutics Inc (NRIX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -249 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -32 | 0.6 | -0.1 | -84 | -160 | -81 | -173 | -249 | |
| 3.0 | 2.4 | 2.2 | 6.1 | 11 | 14 | 16 | 19 | |
| 0.4 | 0.5 | 4.3 | 16 | 28 | 34 | 34 | 38 | |
| 0.1 | 0.4 | 4.6 | 18 | 28 | – | – | – | |
| -25 | 20 | 36 | 9.1 | -19 | 20 | -18 | -32 | |
| 1.6 | 1.7 | 4.6 | 5.7 | 12 | 8.4 | 9.3 | 14 | |
| 40 | 8.5 | -254 | -108 | 27 | 68 | -258 | 148 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 117 | – | – | – | |
| 0.5 | 0.1 | 339 | 154 | 117 | 3.2 | 486 | 239 | |
| 8.8 | 9.2 | 85 | -39 | -15 | -9.8 | 55 | 137 | |
| -33 | -1.1 | -4.6 | -90 | -172 | -90 | -182 | -263 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.